Literature DB >> 19525872

Positive association between Helicobacter pylori and gastroesophageal reflux disease in children.

Aeri Moon1, Aliza Solomon, Debra Beneck, Susanna Cunningham-Rundles.   

Abstract

OBJECTIVES: The role of Helicobacter pylori (H pylori) in gastroesophageal reflux disease (GERD) remains controversial, particularly in children, because there are limited published data. Adult studies suggested that H pylori infection may protect against GERD by causing atrophic gastritis, which leads to reduced gastric acid secretion. The objective of our study was to determine the role of H pylori infection in the development of GERD in a pediatric population. PATIENTS AND METHODS: A retrospective analysis of 420 patients (M:F = 214:206) who underwent esophagogastroduodenoscopy (EGD) with biopsies between January 2000 and April 2006 was conducted. Patient demographics, clinical indications for EGD and the prevalence of reflux esophagitis (RE), the biomarker for GERD, in 2 groups, H pylori positive and H pylori negative, were reviewed. The prevalence of RE in the H pylori-positive and H pylori-negative groups was further analyzed on the basis of sex and age (<1 year, 1-10 years, >10 years). The mean age of the study population was 8.2 years (range 0-20 years). The clinical indications for EGD were as follows: recurrent abdominal pain (n = 186, 44%), malabsorption (n = 80, 19%), persistent vomiting (n = 80, 19%), suspected eosinophilic gastrointestinal disorders (n = 63, 15%), and others such as upper gastrointestinal bleeding or inflammatory bowel disease surveillance (n = 11, 3%). Statistical analysis was performed by using chi test, Fisher exact test, and multivariate logistical regression analysis.
RESULTS: Among the 420 patients, 16 patients (3.8%) were positive for H pylori and 167 patients (39.8%) were found to have RE. Thirteen patients with H pylori were found to have histologic evidence of RE. The prevalence of RE in the H pylori-positive population was 81.3% compared with 38.1% in the H pylori-negative population (P < or = 0.05). There were no patients with H pylori in the youngest age group. In the second age group (1-10 years), 100% of the H pylori-positive patients had RE, whereas 44.6% of the H pylori-negative patients had RE (P < or = 0.05). Both male and female patients with H pylori had a higher prevalence of RE, 77.8% and 85.7%, respectively. On a multivariate logistical regression, for the overall study cohort, H pylori-positive patients had an odds ratio of 5.79 of developing RE compared with H pylori-negative patients (P < or = 0.05).
CONCLUSIONS: Our study results indicate that there is a significantly higher prevalence of RE in an H pylori-infected cohort independent of age or sex. The findings suggest that H pylori infection in children is positively associated with RE.

Entities:  

Mesh:

Year:  2009        PMID: 19525872      PMCID: PMC2732756          DOI: 10.1097/MPG.0b013e31818eb8de

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  39 in total

1.  Helicobacter pylori infection in children: recommendations for diagnosis and treatment.

Authors:  B D Gold; R B Colletti; M Abbott; S J Czinn; Y Elitsur; E Hassall; C Macarthur; J Snyder; P M Sherman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-11       Impact factor: 2.839

2.  Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.

Authors:  W Schwizer; M Thumshirn; J Dent; I Guldenschuh; D Menne; G Cathomas; M Fried
Journal:  Lancet       Date:  2001-06-02       Impact factor: 79.321

Review 3.  Helicobacter pylori infection in children.

Authors:  B D Gold
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2001-09

4.  Helicobacter pylori infection in children of Texas.

Authors:  A R Opekun; M A Gilger; S M Denyes; M H Nirken; S P Philip; M S Osato; H M Malaty; J Hicks; D Y Graham
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-10       Impact factor: 2.839

5.  Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis.

Authors:  T Koike; S Ohara; H Sekine; K Iijima; K Kato; T Shimosegawa; T Toyota
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

6.  Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in children.

Authors:  Aliye Uc; Sonny K F Chong
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-03       Impact factor: 2.839

7.  Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?

Authors:  C A Fallone; A N Barkun; G Friedman; S Mayrand; V Loo; R Beech; L Best; L Joseph
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

8.  Treatment and long-term follow-up of Helicobacter pylori-associated duodenal ulcer disease in children.

Authors:  D M Israel; E Hassall
Journal:  J Pediatr       Date:  1993-07       Impact factor: 4.406

9.  Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial.

Authors:  W L Peterson; D Y Graham; B Marshall; M J Blaser; R M Genta; P D Klein; C W Stratton; J Drnec; P Prokocimer; N Siepman
Journal:  Am J Gastroenterol       Date:  1993-11       Impact factor: 10.864

10.  A 2-year study of Helicobacter pylori in children.

Authors:  J Raymond; M Bergeret; P H Benhamou; K Mensah; C Dupont
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

View more
  12 in total

Review 1.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

Review 2.  Role of nutrients in the development of neonatal immune response.

Authors:  Susanna Cunningham-Rundles; Hong Lin; Deborah Ho-Lin; Ann Dnistrian; Barrie R Cassileth; Jeffrey M Perlman
Journal:  Nutr Rev       Date:  2009-11       Impact factor: 7.110

3.  Gastroesophageal reflux symptoms and associated factors in adolescents: A community-based study.

Authors:  Oleg Reshetnikov; Svetlana Kurilovich
Journal:  Indian J Gastroenterol       Date:  2014-06-12

Review 4.  Helicobacter pylori infection in children: an overview of diagnostic methods.

Authors:  Parisa Sabbagh; Mostafa Javanian; Veerendra Koppolu; VeneelaKrishna Rekha Vasigala; Soheil Ebrahimpour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-07       Impact factor: 3.267

5.  Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry.

Authors:  Dipti Chourasia; Asha Misra; Shweta Tripathi; Narendra Krishnani; Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2011-01-26

6.  Prevalence of Helicobacter Pylori among Sudanese children admitted to a specialized children hospital.

Authors:  Karimeldin M A Salih; Omer A Elfaki; Yassin H M Hamid; Widad M A Eldouch; Mona Diab; Sulafa O Abdelgadir
Journal:  Sudan J Paediatr       Date:  2017

Review 7.  Interactions between Helicobacter pylori and gastroesophageal reflux disease.

Authors:  Oya Yucel
Journal:  Esophagus       Date:  2018-08-27       Impact factor: 4.230

8.  The Association between Childhood Overweight and Reflux Esophagitis.

Authors:  Nirav R Patel; Mary J Ward; Debra Beneck; Susanna Cunningham-Rundles; Aeri Moon
Journal:  J Obes       Date:  2010-05-05

9.  Prevalence of gastroesophageal reflux disease symptoms and related factors in patients with rheumatoid arthritis.

Authors:  Akihide Nampei; Kenrin Shi; Kosuke Ebina; Tetsuya Tomita; Kazuomi Sugamoto; Hideki Yoshikawa; Makoto Hirao; Jun Hashimoto
Journal:  J Clin Biochem Nutr       Date:  2013-02-06       Impact factor: 3.114

10.  Helicobacter pylori infection has no impact on manometric and pH-metric findings in adolescents and young adults with gastroesophageal reflux and antral gastritis: eradication results to no significant clinical improvement.

Authors:  Ioannis Xinias; Theophanis Maris; Antigoni Mavroudi; Christos Panteliadis; Yvan Vandenplas
Journal:  Pediatr Rep       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.